Biotechnology Anti-Counterfeiting Group Identifies Fake Diabetes Drug Ozempic in 16 Countries: Sparks Patient Harm Concerns – Novo Nordisk (NYSE:NVO) Read more
Biotechnology Biodexa Takes Aim At Type 1 Diabetes With Innovative Drug Candidate Tolimidone – Invesco Dorsey Wright Financial Momentum ETF (NASDAQ:PFI), Biodexa Pharmaceuticals (NASDAQ:BDRX) Read more
Stockmarkets Morgan Stanley upbeat on Fractyl Health’s stock diabetes, obesity breakthroughs By biedexmarkets.com Read more